AI assistant
ASPIRE MINING LIMITED — Capital/Financing Update 2017
Aug 23, 2017
64354_rns_2017-08-23_9b7d1886-6b53-4c7a-a218-3014747364c6.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Appendix 3B New issue announcement
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12
Name of entity
ASPIRE MINING LIMITED
ABN
46 122 417 243
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
| 1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the+securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) |
Ordinary Shares Unlisted Options |
|---|---|
| 23,833,333 Ordinary Shares 23,833,333 Unlisted Options |
|
| Fully paid Ordinary Shares at an issue price of $0.02 per share Unlisted Options at nil consideration exercisable at $0.025 per share on or before 12 months from the grant of the Options. All the terms and conditions are set out in Annexure 2. |
- See chapter 19 for defined terms.
Appendix 3B Page 1
01/08/2012
Appendix 3B New issue announcement
| 4 Do the+securities rank equally in all respects from the date of allotment with an existing+class of quoted+securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution under rule 7.1A was passed |
Shares – yes Options – yes, on exercise |
|---|---|
| $0.02 per Ordinary Share Options at nil consideration exercisable at $0.025 per share on or before 12 months from the issue date. |
|
| 500,000 Share and Options - Placement - Fully paid Shares and an attaching Option as set out in the Prospectus dated 27 June 2017 and approved by shareholders at the General Meeting held on 26 July 2017. 23,333,333 Shares and Options - Satisfaction of the obligation to pay loan principal by the issue of Shares and Options as approved by the shareholders at the General Meeting held on 26 July 2017 (Resolutions 5 and 6 in the Notice of General Meeting dated 23 June 2017). |
|
| N/A | |
| N/A |
- See chapter 19 for defined terms.
Appendix 3B Page 2
01/08/2012
Appendix 3B New issue announcement
| 6c Number of +securities issued without security holder approval under rule 7.1 6d Number of+securities issued with security holder approval under rule 7.1A 6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of securities issued under an exception in rule 7.2 6g If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation. 6h If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 Dates of entering+securities into uncertificated holdings or despatch of certificates 8 Number and +class of all +securities quoted on ASX (_including_the securities in section 2 if applicable) |
N/A | N/A |
|---|---|---|
| Rule 7.1: 145,192,751 – see Annexure 1 Rule 7.1A: Nil |
||
| 24 August 2017 | ||
| Number | +Class | |
| 1,023,790,554 | Ordinary Shares |
- See chapter 19 for defined terms.
Appendix 3B Page 3
01/08/2012
Appendix 3B New issue announcement
Number +Class 9 Number and +class of all +securities not quoted on ASX 54,500,000 Performance Rights ( including the securities in section 2 if applicable) 78,755,583 Options
10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)
N/A
Part 2 - Bonus issue or pro rata issue
| 11 Is security holder approval required? 12 Is the issue renounceable or non- renounceable? 13 Ratio in which the+securities will be offered 14 +Class of+securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has+security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations 20 Names of any underwriters |
N/A |
|---|---|
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A |
- See chapter 19 for defined terms.
Appendix 3B Page 4
01/08/2012
Appendix 3B New issue announcement
| 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders 25 If the issue is contingent on +security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if applicable) 29 Date rights trading will end (if applicable) 30 How do+security holders sell their entitlements_in full_through a broker? 31 How do+security holders sell_part_ of their entitlements through a broker and accept for the balance? 32 How do+security holders dispose of their entitlements (except by sale through a broker)? 33 +Despatch date |
N/A |
|---|---|
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A |
- See chapter 19 for defined terms.
Appendix 3B Page 5
01/08/2012
Appendix 3B New issue announcement
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
-
34 Type of securities ( tick one )
-
(a) [Securities described in Part 1 – Ordinary Shares ]
-
(b)[All other securities ]
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over 37 A copy of any trust deed for the additional[+] securities
Entities that have ticked box 34(b)
38 Number of securities for which +quotation is sought
39 Class of +securities for which quotation is sought
- See chapter 19 for defined terms.
Appendix 3B Page 6
01/08/2012
Appendix 3B New issue announcement
40 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted +securities?
If the additional securities do not rank equally, please state:
the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
41 Reason for request for quotation now
Example: In the case of restricted securities, end of restriction period
(if issued upon conversion of another security, clearly identify that other security)
42 Number and[+] class of all[+] securities quoted on ASX ( including the securities in clause 38)
Number +Class
- See chapter 19 for defined terms.
Appendix 3B Page 7
01/08/2012
Appendix 3B New issue announcement
Quotation agreement
-
1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.
-
2 We warrant the following to ASX.
-
The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.
-
There is no reason why those[+] securities should not be granted[+] quotation.
-
An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-
Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.
-
If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.
-
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
-
4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: ............................... Company Secretary
Date: 24 August 2017
Print name: Phil Rundell
- See chapter 19 for defined terms.
Appendix 3B Page 8
01/08/2012
Appendix 3B New issue announcement
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities
Introduced 01/08/12
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
-
Insert number of fully paid ordinary 928,288,306
-
securities on issue 12 months before date of issue or agreement to issue Add the following: • Number of fully paid ordinary securities 9,463,333 issued in that 12 month period under an exception in rule 7.2
-
• Number of fully paid ordinary securities 78,755,583 issued in that 12 month period with shareholder approval
-
• Number of partly paid ordinary securities that became fully paid in that 12 month period
-
Note: • Include only ordinary securities here – other classes of equity securities cannot be added
-
• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed
-
• It may be useful to set out issues of securities on different dates as separate line items
-
Subtract the number of fully paid ordinary securities cancelled during that 12 month period 1,016,507,222
-
“A”
- See chapter 19 for defined terms.
Appendix 3B Page 9
01/08/2012
Appendix 3B New issue announcement
Step 2: Calculate 15% of “A”
| Step 2: Calculate 15% of “A” | |
|---|---|
| “B” | 0.15 |
| [Note: this value cannot be changed] | |
| Multiply“A” by 0.15 | 152,476,083 |
| Step 3: Calculate “C”, the amount of placement capacity under rule | |
| 7.1 that has already been used | |
| Insertnumber of equity securities issued or | 7,283,332 |
| agreed to be issued in that 12 month period | |
| _not counting_those issued: | |
| • Under an exception in rule 7.2 | |
| • Under rule 7.1A | |
| • With security holder approval under rule | |
| 7.1 or rule 7.4 | |
| Note: | |
| • This applies to equity securities, unless | |
| specifically excluded – not just ordinary | |
| securities | |
| • Include here (if applicable ) the | |
| securities the subject of the Appendix | |
| 3B to which this form is annexed | |
| • It may be useful to set out issues of | |
| securities on different dates as separate | |
| line items |
| 7.1 that has already been used | |
|---|---|
| Insertnumber of equity securities issued or | 7,283,332 |
| agreed to be issued in that 12 month period | |
| _not counting_those issued: | |
| • Under an exception in rule 7.2 | |
| • Under rule 7.1A | |
| • With security holder approval under rule | |
| 7.1 or rule 7.4 | |
| Note: | |
| • This applies to equity securities, unless | |
| specifically excluded – not just ordinary | |
| securities | |
| • Include here (if applicable ) the | |
| securities the subject of the Appendix | |
| 3B to which this form is annexed | |
| • It may be useful to set out issues of | |
| securities on different dates as separate | |
| line items | |
| “C” | |
| Step 4: Subtract “C” from [“A” x “B”] to calculate remaining | |
| placement capacity under rule 7.1 | |
| “A” x 0.15 | 152,476,083 |
| Note: number must be same as shown in | |
| Step 2 |
| placement capacity under rule 7.1 | |
|---|---|
| “A” x 0.15 | 152,476,083 |
| Note: number must be same as shown in | |
| Step 2 | |
| Subtract“C” | (7,283,332) |
| Note: number must be same as shown in | |
| Step 3 | |
| Total[“A” x 0.15] – “C” | 145,192,751 |
| Note: this is the remaining placement | |
| capacity under rule 7.1 |
- See chapter 19 for defined terms.
Appendix 3B Page 10
01/08/2012
Appendix 3B New issue announcement
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
“A” N/A Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 N/A
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used
==> picture [415 x 228] intentionally omitted <==
----- Start of picture text -----
Insert number of equity securities issued or N/A
agreed to be issued in that 12 month period
under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
“E” Nil
----- End of picture text -----
- See chapter 19 for defined terms.
Appendix 3B Page 11
01/08/2012
Appendix 3B New issue announcement
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
| Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A |
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A |
|---|---|
| “A” x 0.10 Note: number must be same as shown in Step 2 |
N/A |
| Subtract“E” Note: number must be same as shown in Step 3 |
N/A |
| Total[“A” x 0.10] – “E” | Nil Note: this is the remaining placement capacity under rule 7.1A |
- See chapter 19 for defined terms.
Appendix 3B Page 12
01/08/2012
Appendix 3B New issue announcement
Appendix 3B – Annexure 2
OPTION TERMS
The terms and conditions of the Options are as follows:
(a) Entitlement
Each Option entitles the holder to subscribe for one Share upon exercise of the Option.
The Options held by each holder may be exercised in whole or in part, and if exercised in part, multiples of 1,000 must be exercised on each occasion.
(b) Exercise Price
Subject to paragraph (j), the amount payable upon exercise of each Option will be $0.025 ( Exercise Price ).
(c) Expiry Date
Each Option will expire at 5:00 pm (WST) 12 months from the date of grant of the Options ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.
(d) Exercise Period
The Options are exercisable at any time on or prior to the Expiry Date ( Exercise Period ).
(e)
Notice of Exercise
The Options may be exercised during the Exercise Period by notice in writing to the Company in the manner specified on the Option certificate ( Notice of Exercise ) and payment of the Exercise Price for each Option being exercised in Australian currency by electronic funds transfer or other means of payment acceptable to the Company.
(f) Exercise Date
A Notice of Exercise is only effective on and from the later of the date of receipt of the Notice of Exercise and the date of receipt of the payment of the Exercise Price for each Option being exercised in cleared funds ( Exercise Date ).
(g) Timing of issue of Shares on exercise
Within 10 Business Days after the Exercise Date, the Company will:
(i) allot and issue the number of Shares required under these terms and conditions in respect of the number of Options specified in the Notice of Exercise and for which cleared funds have been received by the Company; and
- See chapter 19 for defined terms.
Appendix 3B Page 13
01/08/2012
Appendix 3B New issue announcement
- (ii) if admitted to the official list of ASX at the time, apply for official quotation on ASX of Shares issued pursuant to the exercise of the Options.
(h) Shares issued on exercise
Shares issued on exercise of the Options rank pari passu in all respects with the issued shares of the Company.
(i)
Quotation of shares issued on exercise
The Company will apply for quotation of all shares allotted pursuant to the exercise of Options on ASX within 10 Business Days after the date of allotment of those shares.
(j) Reconstruction of capital
If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.
(k) Participation in new issues
There are no participation rights or entitlements inherent in the Options and holders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options without exercising the Options.
(l) Change in exercise price
An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Option can be exercised.
(m)
Transferability
The Options will be unlisted.
The Options are transferable subject to any restriction or escrow arrangements imposed by ASX or under applicable Australian securities laws.
- See chapter 19 for defined terms.
Appendix 3B Page 14
01/08/2012